Analysis of the clinical characteristics of 25 cases with parenchymal neuro-Behcet's disease.
10.3760/cma.j.cn112138-20230126-00034
- Author:
Yang LI
1
;
Qiang SHI
2
;
Ying LIN
2
;
Meng Yang LIU
2
;
Jia Qi LIU
2
Author Information
1. Department of Neurology, the First Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100853, China.
2. Department of Neurology, the First Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100853, China Chinese People's Liberation Army Medical School, Beijing 100853, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Male;
Female;
Child, Preschool;
Child;
Adolescent;
Young Adult;
Adult;
Middle Aged;
Aged;
Aged, 80 and over;
Behcet Syndrome/diagnosis*;
Interleukin-6;
Retrospective Studies;
Cross-Sectional Studies;
Interleukin-8;
Magnetic Resonance Imaging;
Neurology
- From:
Chinese Journal of Internal Medicine
2023;62(7):808-813
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To retrospectively investigate the clinical data, radiological characteristics, treatment, and outcome of patients with parenchymal neuro-Behcet's disease (P-NBD) with particular emphasis on dizziness. Methods: This was a cross-sectional study of clinical data from 25 patients with a confirmed diagnosis of P-NBD who were admitted to the Department of Neurology of the First Medical Center of Chinese People's Liberation Army General Hospital between 2010 and 2022. The median age of the population was 37 years (range: 17-85 years). Clinical data were retrospectively analyzed, including gender, age of onset, disease duration, clinical manifestations, serum immune indicators, cerebrospinal fluid (CSF) routine biochemical and cytokine levels, cranial and spinal magnetic resonance imaging (MRI) findings, treatment, and outcome. Results: The majority of patients were male (16 cases; 64.0%), the mean age of onset was (28±14) (range: 4-58 years), and the disease course was acute or subacute. Fever was the most common clinical presentation, and the complaint of dizziness was not uncommon (8/25 patients). Analysis of serum immune indices, including complement (C3 and C4), erythrocyte sedimentation rate, interleukin-1 (IL-1), IL-6, IL-8 and tumor necrotic factor-alpha were abnormal in 80.0% of patients (20/25). Most of the 16/25 patients who underwent lumbar puncture tests had normal intracranial pressure and increased CSF white cell count and protein [median values were 44 (15-380) ×106/L and 0.73 (0.49-2.81) g/L, respectively]. Of the five patients who underwent CSF cytokine tests, four patients had abnormal results; of these, an elevated level of IL-6 was most common, followed by IL-1 and IL-8. The most common site of involvement in cranial MRI was the brainstem and basal ganglia (60.0% respectively), followed by white matter (48.0%) and the cortex (44.0%). Nine cases (36.0%) showed lesions with enhancement and six cases (24.0%) showed mass-like lesions. Three patients (12.0%) patients had lesions in the spinal cord, most frequently in the thoracic cord. All patients received immunological intervention therapy; during follow up, the majority had a favorable outcome. Conclusions: P-NBD is an autoimmune disease with multiple system involvement and diverse clinical manifestations. The symptom of dizziness is not uncommon and can be easily ignored. Early treatment with immunotherapy is important and can improve the outcome of these patients.
